ME-1071

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameME-1071
Drug Alias NameCP-3242ME11071
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBeta Lactamase inhibitors
TargetsBeta Lactamase
Therapy Area/IndicationsPseudomonas InfectionsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMeiji Seika Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMeiji Seika Pharma
Active IndicationsN/A
Inactive IndicationsPseudomonas InfectionsGram-Negative Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A